Search research articles
Contact Us
Filters
Showing results (1-10 of 529) with videos related to
Page
of 53
Sort By:
Schweizerische Zeitschrift Fur Tuberkulose. Revue Suisse De La Tuberculose. Rivista Svizzera Della Tubercolosi
|
March 19, 2010
Artificial paralysis of the diaphragm and pneumoperitoneum
J MORIN
Oncogene
|
June 28, 2001
From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents
M J Morin
Endocrine-Related Cancer
|
May 10, 2014
Embracing change
Pat J Morin
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
September 10, 2003
Drug resistance and the microenvironment: nature and nurture
Patrice J Morin
Biochemical Pharmacology
|
March 15, 1974
Inhibition of ovarian cholesterol esterification by diethylaminoethyl diphenylvalerate (SKF 525-A) and other ionic amphipathic amines
R J Morin
The Journal of Clinical Investigation
|
January 15, 2019
Colorectal cancer: the APC-lncRNA link
Pat J Morin
Therapeutic Innovation & Regulatory Science
|
January 15, 2020
Harmonizing Protocol Complexity with Resource Management and Capacity Planning at Clinical Research Sites
David J Morin
Therapeutic Innovation & Regulatory Science
|
May 2, 2018
Use of Proxy Variables to Determine the Impact of Protocol Complexity on Clinical Research Site Productivity
David J Morin
Cancer Research
|
November 4, 2005
Claudin proteins in human cancer: promising new targets for diagnosis and therapy
Patrice J Morin
Lancet (London, England)
|
March 11, 1972
Arterial cholesterol and vitamin C
R J Morin
Page
of 53
Search research articles
Search
Showing results (1-10 of 529) with videos related to
Sort By:
Page
of 53
Schweizerische Zeitschrift Fur Tuberkulose. Revue Suisse De La Tuberculose. Rivista Svizzera Della Tubercolosi
|
March 19, 2010
Artificial paralysis of the diaphragm and pneumoperitoneum
J MORIN
Oncogene
|
June 28, 2001
From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents
M J Morin
Endocrine-Related Cancer
|
May 10, 2014
Embracing change
Pat J Morin
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
September 10, 2003
Drug resistance and the microenvironment: nature and nurture
Patrice J Morin
Biochemical Pharmacology
|
March 15, 1974
Inhibition of ovarian cholesterol esterification by diethylaminoethyl diphenylvalerate (SKF 525-A) and other ionic amphipathic amines
R J Morin
The Journal of Clinical Investigation
|
January 15, 2019
Colorectal cancer: the APC-lncRNA link
Pat J Morin
Therapeutic Innovation & Regulatory Science
|
January 15, 2020
Harmonizing Protocol Complexity with Resource Management and Capacity Planning at Clinical Research Sites
David J Morin
Therapeutic Innovation & Regulatory Science
|
May 2, 2018
Use of Proxy Variables to Determine the Impact of Protocol Complexity on Clinical Research Site Productivity
David J Morin
Cancer Research
|
November 4, 2005
Claudin proteins in human cancer: promising new targets for diagnosis and therapy
Patrice J Morin
Lancet (London, England)
|
March 11, 1972
Arterial cholesterol and vitamin C
R J Morin
Page
of 53